SQT1665 Citations (3)

Originally described in: Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Kleinstiver BP, Tsai SQ, Prew MS, Nguyen NT, Welch MM, Lopez JM, McCaw ZR, Aryee MJ, Joung JK Nat Biotechnol. 2016 Jun 27. doi: 10.1038/nbt.3620. PubMed Journal

---

Articles Citing SQT1665

Articles
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration. Koo T, Park SW, Jo DH, Kim D, Kim JH, Cho HY, Kim J, Kim JH, Kim JS. Nat Commun. 2018 May 10;9(1):1855. doi: 10.1038/s41467-018-04175-y. PubMed
Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA. Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15. PubMed
CRISPR/Cas12a mediated knock-in of the Polled Celtic variant to produce a polled genotype in dairy cattle. Schuster F, Aldag P, Frenzel A, Hadeler KG, Lucas-Hahn A, Niemann H, Petersen B. Sci Rep. 2020 Aug 11;10(1):13570. doi: 10.1038/s41598-020-70531-y. PubMed

If you have published an article using this material, please email us at to have your article added to this page.